Techno Medica Beheer

Beheer criteriumcontroles 2/4

Techno Medica's CEO is Masatomo Saneyoshi, appointed in Jun 2014, has a tenure of 10.42 years. directly owns 2.99% of the company’s shares, worth ¥369.29M. The average tenure of the management team and the board of directors is 8.4 years and 6.4 years respectively.

Belangrijke informatie

Masatomo Saneyoshi

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	10.4yrs
Eigendom CEO	3.0%
Management gemiddelde ambtstermijn	8.4yrs
Gemiddelde ambtstermijn bestuur	6.4yrs

Recente managementupdates

Recent updates

CEO

Masatomo Saneyoshi (51 yo)

10.4yrs

Tenure

Mr. Masatomo Saneyoshi has been the President of Techno Medica Co., Ltd., since June 2014 and serves as its Chief Executive Officer since June 01, 2014. Mr. Saneyoshi served as Assistant to The President a...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Masatomo Saneyoshi	Chairman	10.4yrs	geen gegevens	2.99% ¥ 369.3m
Masato Takeda	GM of Sales Headquarters & Director	8.3yrs	geen gegevens	0.23% ¥ 28.7m
Yasushi Nakano	GM of Medical Solutions Development Department	8.6yrs	geen gegevens	0.13% ¥ 15.9m
Shiro Nakahara	Head of Business Management Division & Director	less than a year	geen gegevens	0.012% ¥ 1.4m

8.4yrs

Gemiddelde duur

58.5yo

Gemiddelde leeftijd

Ervaren management: 6678's management team is seasoned and experienced (8.4 years average tenure).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Masatomo Saneyoshi	Chairman	15.4yrs	geen gegevens	2.99% ¥ 369.3m
Masato Takeda	GM of Sales Headquarters & Director	15.4yrs	geen gegevens	0.23% ¥ 28.7m
Yasushi Nakano	GM of Medical Solutions Development Department	5.4yrs	geen gegevens	0.13% ¥ 15.9m
Shiro Nakahara	Head of Business Management Division & Director	less than a year	geen gegevens	0.012% ¥ 1.4m
Jun Ozeki	Independent Outside Director	7.4yrs	geen gegevens	0.027% ¥ 3.4m
Yutaka Hirai	Independent Outside Director	less than a year	geen gegevens	0.019% ¥ 2.3m

6.4yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: 6678's board of directors are considered experienced (6.4 years average tenure).

Techno Medica Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Techno Medica Co., Ltd., Annual General Meeting, Jun 26, 2024

Techno Medica Co., Ltd., Annual General Meeting, Jun 28, 2023

Less than half of directors are independent

Recent updates

First quarter 2025 earnings released: EPS: JP¥25.10 (vs JP¥8.73 in 1Q 2024)

Full year 2024 earnings released: EPS: JP¥173 (vs JP¥136 in FY 2023)

Techno Medica Co., Ltd., Annual General Meeting, Jun 26, 2024

Techno Medica Co., Ltd. Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 27, 2024

Upcoming dividend of JP¥55.00 per share

Techno Medica Co., Ltd. to Report Fiscal Year 2024 Results on May 09, 2024

Third quarter 2024 earnings released: EPS: JP¥34.20 (vs JP¥30.09 in 3Q 2023)

Techno Medica Co., Ltd. (TSE:6678) announces an Equity Buyback for 1,220,000 shares, representing 15.08% for ¥2,836.5 million.

Second quarter 2024 earnings released: EPS: JP¥37.61 (vs JP¥26.35 in 2Q 2023)

First quarter 2024 earnings released: EPS: JP¥8.73 (vs JP¥10.33 in 1Q 2023)

Techno Medica Co., Ltd. Announces Dividend for the Year Ended March 31, 2023, Payable on June 29, 2023

Techno Medica Co., Ltd. (TSE:6678) announces an Equity Buyback for 400,000 shares, for ¥724.4 million.

Full year 2023 earnings released: EPS: JP¥136 (vs JP¥151 in FY 2022)

Techno Medica Co., Ltd., Annual General Meeting, Jun 28, 2023

Upcoming dividend of JP¥55.00 per share at 2.8% yield

Third quarter 2023 earnings released: EPS: JP¥30.09 (vs JP¥24.11 in 3Q 2022)

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥26.35 (vs JP¥34.86 in 2Q 2022)

Techno Medica Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

First quarter 2023 earnings released: EPS: JP¥10.33 (vs JP¥20.07 in 1Q 2022)

Techno Medica Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Full year 2022 earnings released: EPS: JP¥151 (vs JP¥136 in FY 2021)

Techno Medica Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Techno Medica Co., Ltd. to Report Q3, 2023 Results on Feb 01, 2023

Upcoming dividend of JP¥51.00 per share

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Techno Medica Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2022

Second quarter 2022 earnings released: EPS JP¥34.86 (vs JP¥26.17 in 2Q 2021)

First quarter 2022 earnings released: EPS JP¥20.07 (vs JP¥6.96 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥136 (vs JP¥118 in FY 2020)

Inaugural dividend of JP¥49.00 per share

Techno Medica Co., Ltd. to Report Fiscal Year 2021 Results on May 12, 2021

New 90-day high: JP¥1,647

Third quarter 2021 earnings released: EPS JP¥31.67 (vs JP¥20.99 in 3Q 2020)

New 90-day low: JP¥1,488

Techno Medica Co., Ltd. to Report Q2, 2021 Results on Nov 04, 2020

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd